Top Reasons to Attend:

1. To hear FDA’s position on particulate matter in Therapeutic Protein and Cell Therapy Products
2. To learn how to manage particulate matter over the entire lifecycle of a product
3. To learn how one performs a safety evaluation of particulate matter in therapeutic proteins
4. To learn about visual inspection of particulate matter and best practices for training, training sets and setting thresholds
5. To learn about control strategies for sub-visible and visible particulate matter
6. To learn about statistical tools for the assessment of particulate matter
   For more information click here

• Analytical chemists and biologists
• QA/QC analysts
• R&D scientists, managers
• Manufacturing scientists, managers
• Regulatory affairs specialists
• Contract research organizations
• Contract manufacturing organizations